SK Hynix (SKHY) Backs A US$38b HBM Buildout, Is The Valuation Discount Too Harsh?

SK hynix (NasdaqGS:SKHY) approved a roughly US$38b program to build new high bandwidth memory focused fabs in South Korea, a large expansion that brings long term capital commitments into sharper focus for current and potential shareholders.

See our latest analysis for SK hynix.

Despite the expansion plans and supportive policy moves around South Korea's semiconductor sector in recent weeks, SK hynix's 30 day share price return is down 19.48%, and the year to date share price return matches that weaker tone. This signals fading momentum as investors reassess execution risk around large scale memory investments.

If this kind of semiconductor story interests you, it can be useful to compare SK hynix with other chip focused opportunities by running through the 56 AI infrastructure stocks

SK hynix now trades well below both intrinsic value estimates and the average analyst price target after the recent slide. Is the market rightly cautious about the new US$38b build out, or is the discount too harsh?

Price-to-Earnings of 6.4x: Is it justified?

On simple numbers, SK hynix looks inexpensive. The stock last closed at $135.29, while the company is described as trading at a P/E of 6.4x compared with a peer average of 59.8x and a US Semiconductor industry average of 49.5x.

The P/E ratio compares what investors pay today for each dollar of earnings. For SK hynix, a 6.4x P/E suggests the market is attaching a much lower earnings multiple than it is for similar semiconductor companies. Earnings and revenue are both reported as growing strongly.

That gap to peers is wide. If the industry trades around 50x earnings and SK hynix sits at 6.4x, the market is clearly applying a heavy discount to the stock relative to sector norms.

See what the numbers say about this price — find out in our valuation breakdown.

Result: Price-to-Earnings of 6.4x (UNDERVALUED)

However, investors still face risks around execution on the US$38b expansion, and the recent share price decline of 19.48% over 30 days could signal fragile sentiment.

Find out about the key risks to this SK hynix narrative.

Another view on SK hynix valuation

The P/E comparison paints SK hynix as inexpensive, yet the SWS DCF model presents an even stronger view. It puts fair value at $526.44 per share versus a current price of $135.29, which suggests the stock trades at a steep discount. How comfortable are you with the assumptions behind that cash flow path?

Look into how the SWS DCF model arrives at its fair value.

Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out SK hynix for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 51 high quality undervalued stocks. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity.

Next Steps

Sentiment around SK hynix in this article may feel mixed, so it makes sense to move quickly, review the data yourself and decide where you stand. To weigh up both the concerns and the potential upside in one place, start with the 3 key rewards and 2 important warning signs

Looking for more investment ideas beyond SK hynix?

If SK hynix has sharpened your interest, do not stop here. Broader ideas from the Simply Wall Street screener can help you round out your watchlist wisely.

• Target potential mispricings by scanning a curated set of companies that currently look cheap on quality metrics through the 51 high quality undervalued stocks.
• Strengthen your income focus by reviewing stocks that currently offer higher yields and more robust payouts using the 9 dividend fortresses.
• Dial down overall risk by checking companies that currently score well on resilience through the 83 resilient stocks with low risk scores.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com